Thermo Fisher Scientific | TMO - Selling And Administration Expenses

Stock Price
469.71
Daily Change
3.01 0.64%
Monthly
-4.29%
Yearly
10.72%
Q2 Forecast
515.01

Thermo Fisher Scientific reported $1.8B in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Abbott USD 3.27B 138M Mar/2026
Agilent USD 476M 48M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Bio Techne USD 113.69M 2.52M Dec/2025
Bio-Rad Laboratories USD 206.8M 900K Sep/2025
Boston Scientific USD 1.83B 93M Dec/2025
Bruker USD 247.2M 4.7M Dec/2025
Charles River Laboratories USD 196.14M 18.55M Dec/2025
Danaher USD 1.86B 166M Mar/2026
Dentsply International USD 383M 28M Dec/2025
Edwards Lifesciences USD 522.2M 80.7M Mar/2026
General Electric Aerospace USD 1.08B 496M Mar/2026
Henry Schein USD 808M 48M Dec/2025
Illumina USD 283M 27M Dec/2025
Intuitive Surgical USD 613.3M 73.8M Mar/2026
IQVIA Holdings USD 468M 46M Dec/2025
Laboratory Of America USD 538.6M 13.8M Dec/2025
Medtronic 2.97B 159M Sep/2025
Mettler Toledo International USD 259.83M 11.43M Dec/2025
Myriad Genetics USD 122.3M 6.7M Dec/2025
Olympus JPY 125.65B 5.75B Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Quest Diagnostics USD 504M 0 Mar/2026
Repligen USD 74.36M 703K Dec/2025
Revvity USD 251.73M 9.82M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Veracyte USD 43.31M 8.43M Dec/2025
Waters USD 240.01M 25.78M Dec/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025